1. Richeldi L et al. N Engl J Med 2014;370:2071–82.
2. Kolb M et al. N Engl J Med 2018;379:1722–31.
3. Selman M et al. Poster developed for ATS 2020.
   Available at: https://www.usscicomms.com/respiratory/ats2020/selman

The INSTAGE trial was funded by Boehringer Ingelheim. Editorial and formatting assistance, supported financially by Boehringer Ingelheim, was provided by Elizabeth Ng and Wendy Morris of FleishmanHillard Fishburn, London, UK during preparation of this poster. The authors were fully responsible for all content and editorial decisions, were involved at all stages of poster development and have approved the final version. Boehringer Ingelheim was given the opportunity to review the poster for medical and scientific accuracy as well as intellectual property considerations. The authors received no direct compensation related to the development of this poster. Eric S White is now an employee of Boehringer Ingelheim Pharmaceuticals, Inc. Francesco Bonella has received honoraria and personal fees from Boehringer Ingelheim. Fernando J Martinez reports being on Steering Committees for ILD studies sponsored by Bayer, Biogen, Gilead, Nitto, Patara/Respivant, ProMedior, ProMetic, and Veracyte; a member of the Data and Safety Monitoring Board for studies supported by Biogen, Boehringer Ingelheim, and Genentech; and a consultant for Boehringer Ingelheim, Genentech, and Zambon.